Chronic hepatitis B is a common liver infection, particularly in Asia, where many people were exposed to the virus at birth or during childhood. In Singapore and across the region, many adults live with hepatitis B for decades without experiencing symptoms.
However, even when patients feel completely well, hepatitis B can silently affect the liver over time. This is why regular follow-up with a specialist is essential for anyone diagnosed with chronic hepatitis B.
Recent updates to international hepatitis B management guidelines have also changed how doctors decide when treatment should begin, with growing evidence supporting treatment in patients with lower viral loads than previously recommended. As a result, patients who were previously monitored without treatment may now benefit from therapy.
Regular follow-up allows your specialist to detect these changes early and recommend the most appropriate management for your liver health.
Hepatitis B Can Change Over Time
One of the key challenges in managing hepatitis B is that it is a dynamic disease. The activity of the virus can fluctuate, and patients may move between different phases of infection during their lifetime.
A patient who previously had a low viral load and normal liver tests may later develop:
- An increase in hepatitis B viral levels
- Signs of liver inflammation
- Early liver scarring (fibrosis)
Because these changes often occur without noticeable symptoms, routine monitoring is essential.
During follow-up visits, your gastroenterologist may assess several important markers, including:
- HBV DNA (viral load) – measures the amount of virus in the blood
- Liver enzyme levels (ALT and AST) – indicates inflammation in the liver
- Liver fibrosis or stiffness – evaluated using scans such as FibroScan
- Ultrasound screening – to detect early liver cancer in higher-risk patients
These tests provide a clearer picture of whether the infection is stable or becoming more active.
New Guidelines Suggest Earlier Treatment in Some Patients
Historically, treatment for hepatitis B was recommended mainly for patients who had:
- High viral loads (often above 20,000 IU/mL)
- Elevated liver enzymes
- Evidence of liver damage
However, recent research has shown that some patients with lower viral loads can still develop progressive liver disease or liver cancer.
As a result, newer international guidelines increasingly support earlier treatment in selected patients, particularly when:
- HBV DNA levels exceed approximately 2,000 IU/mL
- There is evidence of liver fibrosis or inflammation
- Patients are older, especially over 40–50 years
- There is a family history of liver cancer
- Additional liver risk factors are present
This shift reflects a growing understanding that earlier viral suppression may reduce long-term complications.
For many patients, this means that treatment decisions today may be different from recommendations made several years ago. Regular review with a specialist ensures that management remains aligned with the latest medical evidence.
Why Some Patients Still Do Not Need Immediate Treatment
Not every patient with hepatitis B requires antiviral medication right away. Some individuals remain in an inactive phase of infection, where the virus is present but causing little or no liver inflammation.
In these cases, careful monitoring may be the most appropriate strategy.
However, even patients who are not on treatment still require ongoing follow-up, because:
- Viral activity may increase over time
- Liver inflammation can develop gradually
- Treatment criteria may eventually be met
Regular monitoring allows doctors to identify the right moment to start therapy, if needed.
Preventing Long-Term Liver Complications
Without proper monitoring and treatment when indicated, chronic hepatitis B can lead to long-term liver complications such as:
- Liver fibrosis and cirrhosis
- Liver failure
- Hepatocellular carcinoma (liver cancer)
The good news is that modern antiviral medications are highly effective at suppressing the hepatitis B virus.
These medications can:
- Reduce viral replication
- Prevent progression of liver scarring
- Lower the risk of liver cancer
- Improve long-term survival
Many of these treatments are taken once daily and are well tolerated, making long-term management much easier than in the past.
The key is identifying who should start treatment and when.
The Importance of Liver Cancer Screening
Even in patients with stable hepatitis B, there remains a risk of developing liver cancer. This risk is higher in certain groups, including:
- Men over 40 years old
- Women over 50 years old
- Patients with cirrhosis
- Individuals with a family history of liver cancer
For these patients, specialists typically recommend regular liver ultrasound screening every six months.
Early detection of liver cancer significantly improves treatment options and outcomes, which is another reason why regular specialist follow-up is essential.
How Often Should Patients Be Reviewed?
Follow-up intervals vary depending on each patient’s clinical situation. In general:
- Patients not requiring treatment may be reviewed every 6–12 months
- Patients with more active disease may require more frequent monitoring
- Those on antiviral therapy require regular blood tests to assess treatment response
Your gastroenterologist will tailor a monitoring schedule based on your viral load, liver health, age, and individual risk factors.
When Should You See a Specialist?
If you have hepatitis B, you should consider seeing a gastroenterologist or liver specialist if:
- You have not had a review in the past year
- Your last assessment was several years ago
- You were previously told treatment was not necessary
- You have a family history of liver cancer
- You want to understand whether new treatment recommendations apply to you
Because treatment guidelines continue to evolve, a specialist review ensures that your care remains up to date with the latest evidence.
Protecting Your Long-Term Liver Health
Chronic hepatitis B is a condition that requires long-term partnership between patients and their healthcare providers. With regular monitoring and timely treatment when needed, most patients can maintain good liver health and prevent serious complications.
If you have been diagnosed with hepatitis B, continuing regular follow-up with your specialist is one of the most important steps you can take to protect your liver.
Written by:
Dr Mark Fernandes
Gastroenterologist
Dr Mark Fernandes specialises in the diagnosis and management of digestive and liver diseases, including hepatitis B, fatty liver disease, cirrhosis, and liver cancer screening.
